The Board of Directors of Roivant Sciences Ltd. has authorized a buyback plan on April 2, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.06 USD | -1.99% | -2.67% | -1.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.11% | 9.1B | |
+39.65% | 723B | |
+34.28% | 595B | |
-4.06% | 369B | |
+20.30% | 332B | |
+2.78% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.16% | 168B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Ltd. authorizes a Buyback Plan.